Table 2.

Disproportionality analyses and drug interaction approaches for various combinations involving voriconazole.

Exposure	Cases	Non-cases	ROR (95% CI)	p-value
Voriconazole	323	22,516	Reference	Reference
Levodopa	1582	89,228	1.236 (1.096–1.394)	0.001
Risperidone	466	109,291	0.297 (0.258–0.343)	< 0.001
Chlorpromazine	15	6420	0.163 (0.097–0.274)	< 0.001
Voriconazole + Levodopa	3	17	12.302 (3.587–42.183)	< 0.001
Voriconazole + Risperidone	2	81	1.721 (0.421–7.030)	0.449
Voriconazole + Chlorpromazine	0	26	–	–